Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostanoids in platelet-vascular interactions.

T J Martin, I L Smith, R D Nolan

    The American Journal of Cardiology
    |July 20, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of severe, chronic hand eczema: results from a UK-wide survey.

    Clinical and experimental dermatology·2016
    Same author

    THE ETA COEFFICIENT IN MANOVA.

    Multivariate behavioral research·2016
    Same author

    Nox4 and redox signaling mediate TGF-β-induced endothelial cell apoptosis and phenotypic switch.

    Cell death & disease·2014
    Same author

    Arginase II inhibition prevents nitrate tolerance.

    British journal of pharmacology·2012
    Same author

    Emerging tropical diseases in Australia. Part 3. Australian bat lyssavirus.

    Annals of tropical medicine and parasitology·2010
    Same author

    Design and evaluation of consensus PCR assays for henipaviruses.

    Journal of virological methods·2009
    Same journal

    Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

    The American journal of cardiology·2026
    Same journal

    ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

    The American journal of cardiology·2026
    Same journal

    Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

    The American journal of cardiology·2026
    Same journal

    Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

    The American journal of cardiology·2026
    Same journal

    Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

    The American journal of cardiology·2026
    Same journal

    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

    The American journal of cardiology·2026
    See all related articles

    Prostacyclin is a key molecule for vascular health, inhibiting platelet aggregation and relaxing blood vessels. Therapeutic strategies focus on increasing prostacyclin production to treat vascular diseases.

    Area of Science:

    • Biochemistry
    • Vascular Biology
    • Pharmacology

    Background:

    • Prostacyclin, a product of arachidonic acid metabolism, is crucial for maintaining vascular integrity.
    • It acts as a potent inhibitor of platelet aggregation and a vasodilator.
    • While potentially hormonal, its primary role is local, preventing thrombosis and maintaining vessel patency.

    Purpose of the Study:

    • To review the role of prostacyclin in vascular health.
    • To explore factors influencing prostacyclin production.
    • To discuss therapeutic strategies for vascular diseases by modulating prostacyclin levels.

    Main Methods:

    • Literature review of prostacyclin's biochemical pathways and physiological effects.
    • Analysis of factors affecting prostacyclin synthesis, particularly at sites of vascular injury.

    Related Experiment Videos

  • Evaluation of pharmacological approaches to enhance prostacyclin production.

    • Main Results:

    • Prostacyclin is vital for preventing blood clots and maintaining open blood vessels.
    • Local factors at sites of vessel injury significantly influence prostacyclin production.
    • Drugs that increase prostacyclin synthesis show promise for treating vascular conditions.

    Conclusions:

    • Increasing prostacyclin production is a promising therapeutic avenue for vascular diseases.
    • Thromboxane synthesis inhibitors and lipoxygenase inhibitors may enhance prostacyclin levels.
    • Understanding prostacyclin's local regulation is key to developing effective vascular therapies.